Cogent Biosciences Inc (COGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 98,165 | 53,229 | 141,141 | 219,684 | 242,190 |
| Marketable Securities | 188,912 | 212,481 | 119,390 | N/A | N/A |
| TOTAL | $296,472 | $270,771 | $264,966 | $222,633 | $244,912 |
| Non-Current Assets | |||||
| PPE Net | 6,467 | 8,344 | 7,783 | 1,706 | 134 |
| Investments And Advances | 0 | 7,460 | 0 | 0 | 0 |
| Other Non-Current Assets | 24,959 | 26,862 | 28,061 | 7,753 | 5,870 |
| TOTAL | $31,426 | $42,666 | $35,844 | $9,459 | $6,004 |
| Total Assets | $327,898 | $313,437 | $300,810 | $232,092 | $250,916 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,013 | 10,655 | 5,842 | 3,483 | 732 |
| Accrued Expenses | 42,132 | 26,127 | 17,884 | 8,210 | 4,779 |
| Other current liabilities | N/A | N/A | 1,700 | 3,060 | 5,531 |
| TOTAL | $55,710 | $38,168 | $26,849 | $17,077 | $13,094 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 15,902 | 17,467 | 18,226 | 831 | 3,155 |
| TOTAL | $15,902 | $17,467 | $18,226 | $831 | $3,155 |
| Total Liabilities | $71,612 | $55,635 | $45,075 | $17,908 | $16,249 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 113,850 | 103,913 | 69,947 | 45,814 | 37,194 |
| Common Shares | 110 | 86 | 70 | 44 | 32 |
| Retained earnings | -859,483 | -603,624 | -411,214 | -270,973 | -198,700 |
| Other shareholders' equity | 111,047 | 60,281 | 65,726 | 85,400 | 110,881 |
| TOTAL | $256,286 | $257,802 | $255,735 | $214,184 | $234,667 |
| Total Liabilities And Equity | $327,898 | $313,437 | $300,810 | $232,092 | $250,916 |